Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration.
Jiang Y, Alam JJ, Gomperts SN, Maruff P, Lemstra AW, Germann UA, Stavrides PH, Darji S, Malampati S, Peddy J, Bleiwas C, Pawlik M, Pensalfini A, Yang DS, Subbanna S, Basavarajappa BS, Smiley JF, Gardner A, Blackburn K, Chu HM, Prins ND, Teunissen CE, Harrison JE, Scheltens P, Nixon RA.
Jiang Y, et al. Among authors: darji s.
Nat Commun. 2022 Sep 21;13(1):5308. doi: 10.1038/s41467-022-32944-3.
Nat Commun. 2022.
PMID: 36130946
Free PMC article.
Clinical Trial.